Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hong Peng is a pioneering urologic surgeon whose research focuses on minimally invasive surgical techniques for complex urologic conditions, particularly ureteropelvic junction obstruction (UPJO) and renal cell carcinoma with tumor thrombus. His landmark 2018 study, cited 19 times, provided the first head-to-head comparison of modified laparoscopic pyeloplasty versus robot-assisted pyeloplasty for UPJO in Chinese patients, demonstrating that both approaches offer comparable outcomes while establishing modified laparoscopy as a cost-effective alternative in resource-constrained settings. More recently, Dr. Peng’s 2025 large-scale retrospective study from a high-volume center, with 2 citations to date, has broken new ground by proving the safety and feasibility of segmental resection of the inferior vena cava in patients with renal cell carcinoma and tumor thrombus—a procedure previously considered high-risk. This work has significant implications for expanding surgical options in advanced kidney cancer. Dr. Peng’s contributions are characterized by rigorous comparative effectiveness research and a commitment to advancing surgical oncology, making him a respected voice in urologic surgery and a valuable resource for trainees seeking evidence-based approaches to challenging clinical scenarios.